Administration of inotropes.
Davies
N
N
South Buckinghamshire NHS Trust, South Bank University, London.
D019985:Benchmarking; D002303:Cardiac Output, Low / Q000188:drug therapy* / Q000209:etiology; D002316:Cardiotonic Agents / Q000494:pharmacology / Q000627:therapeutic use*; D003422:Critical Care / Q000379:methods* / Q000592:standards; D004280:Dobutamine / Q000494:pharmacology / Q000627:therapeutic use; D004298:Dopamine / Q000494:pharmacology / Q000627:therapeutic use; D016903:Drug Monitoring / Q000379:methods / Q000451:nursing / Q000592:standards; D004837:Epinephrine / Q000494:pharmacology / Q000627:therapeutic use; D006801:Humans; D007262:Infusions, Intravenous / Q000379:methods / Q000451:nursing; D011942:Receptors, Adrenergic, alpha / Q000187:drug effects; D018342:Receptors, Adrenergic, beta-1 / Q000187:drug effects; D018343:Receptors, Adrenergic, beta-2 / Q000187:drug effects
D002316:Cardiotonic Agents; D011942:Receptors, Adrenergic, alpha; D018342:Receptors, Adrenergic, beta-1; D018343:Receptors, Adrenergic, beta-2; D004280:Dobutamine; D004298:Dopamine; D004837:Epinephrine